Literature DB >> 28031340

IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function.

Yin Guo1, Liming Luan2, Naeem K Patil2, Jingbin Wang2, Julia K Bohannon2, Whitney Rabacal1, Benjamin A Fensterheim1, Antonio Hernandez2, Edward R Sherwood3,2.   

Abstract

Interleukin 15 is essential for the development and differentiation of NK and memory CD8+ (mCD8+) T cells. Our laboratory previously showed that NK and CD8+ T lymphocytes facilitate the pathobiology of septic shock. However, factors that regulate NK and CD8+ T lymphocyte functions during sepsis are not well characterized. We hypothesized that IL-15 promotes the pathogenesis of sepsis by maintaining NK and mCD8+ T cell integrity. To test our hypothesis, the pathogenesis of sepsis was assessed in IL-15-deficient (IL-15 knockout, KO) mice. IL-15 KO mice showed improved survival, attenuated hypothermia, and less proinflammatory cytokine production during septic shock caused by cecal ligation and puncture or endotoxin-induced shock. Treatment with IL-15 superagonist (IL-15 SA, IL-15/IL-15Rα complex) regenerated NK and mCD8+ T cells and re-established mortality of IL-15 KO mice during septic shock. Preventing NK cell regeneration attenuated the restoration of mortality caused by IL-15 SA. If given immediately prior to septic challenge, IL-15-neutralizing IgG M96 failed to protect against septic shock. However, M96 caused NK cell depletion if given 4 d prior to septic challenge and conferred protection. IL-15 SA treatment amplified endotoxin shock, which was prevented by NK cell or IFN-γ depletion. IL-15 SA treatment also exacerbated septic shock caused by cecal ligation and puncture when given after the onset of sepsis. In conclusion, endogenous IL-15 does not directly augment the pathogenesis of sepsis but enables the development of septic shock by maintaining NK cell numbers and integrity. Exogenous IL-15 exacerbates the severity of sepsis by activating NK cells and facilitating IFN-γ production.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28031340      PMCID: PMC5263185          DOI: 10.4049/jimmunol.1601486

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization.

Authors:  Kai-ping Han; Xiaoyun Zhu; Bai Liu; Emily Jeng; Lin Kong; Jason L Yovandich; Vinay V Vyas; Warren D Marcus; Pierre-Andre Chavaillaz; Christian A Romero; Peter R Rhode; Hing C Wong
Journal:  Cytokine       Date:  2011-10-22       Impact factor: 3.861

2.  IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis.

Authors:  Georgia Malamut; Raja El Machhour; Nicolas Montcuquet; Séverine Martin-Lannerée; Isabelle Dusanter-Fourt; Virginie Verkarre; Jean-Jacques Mention; Gabriel Rahmi; Hiroshi Kiyono; Eric A Butz; Nicole Brousse; Christophe Cellier; Nadine Cerf-Bensussan; Bertrand Meresse
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

3.  Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice.

Authors:  Oliver Goldmann; Gursharan S Chhatwal; Eva Medina
Journal:  J Infect Dis       Date:  2005-03-04       Impact factor: 5.226

4.  Herpes simplex virus-1 up-regulates IL-15 gene expression in monocytic cells through the activation of protein tyrosine kinase and PKC zeta/lambda signaling pathways.

Authors:  Rasheed Ahmad; Jamila Ennaciri; Paulo Cordeiro; Souad El Bassam; José Menezes
Journal:  J Mol Biol       Date:  2006-12-28       Impact factor: 5.469

5.  Mice depleted of CD8+ T and NK cells are resistant to injury caused by cecal ligation and puncture.

Authors:  Edward R Sherwood; Victor T Enoh; Erle D Murphey; Cheng Y Lin
Journal:  Lab Invest       Date:  2004-12       Impact factor: 5.662

6.  IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities.

Authors:  Zane Orinska; Marcus Maurer; Farhad Mirghomizadeh; Elena Bulanova; Martin Metz; Natalia Nashkevich; Florian Schiemann; Jan Schulmistrat; Vadim Budagian; Julien Giron-Michel; Ernst Brandt; Ralf Paus; Silvia Bulfone-Paus
Journal:  Nat Med       Date:  2007-07-22       Impact factor: 53.440

7.  Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection.

Authors:  Brian Badgwell; Robin Parihar; Cynthia Magro; Julie Dierksheide; Thomas Russo; William Edgar Carson
Journal:  Surgery       Date:  2002-08       Impact factor: 3.982

Review 8.  Animal models of sepsis.

Authors:  Mitchell P Fink
Journal:  Virulence       Date:  2013-08-19       Impact factor: 5.882

9.  IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection.

Authors:  Naeem K Patil; Liming Luan; Julia K Bohannon; Yin Guo; Antonio Hernandez; Benjamin Fensterheim; Edward R Sherwood
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

10.  IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.

Authors:  Erwan Mortier; Tammy Woo; Rommel Advincula; Sara Gozalo; Averil Ma
Journal:  J Exp Med       Date:  2008-05-05       Impact factor: 14.307

View more
  18 in total

1.  Sepsis inhibits tumor growth in mice with cancer through Toll-like receptor 4-associated enhanced Natural Killer cell activity.

Authors:  Clara Vigneron; Adrien Mirouse; Hamid Merdji; Christophe Rousseau; Clément Cousin; Fanny Alby-Laurent; Jean-Paul Mira; Jean-Daniel Chiche; Jean-François Llitjos; Frédéric Pène
Journal:  Oncoimmunology       Date:  2019-07-19       Impact factor: 8.110

Review 2.  The biology of natural killer cells during sepsis.

Authors:  Yin Guo; Naeem K Patil; Liming Luan; Julia K Bohannon; Edward R Sherwood
Journal:  Immunology       Date:  2017-11-16       Impact factor: 7.397

Review 3.  Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent.

Authors:  Yin Guo; Liming Luan; Naeem K Patil; Edward R Sherwood
Journal:  Cytokine Growth Factor Rev       Date:  2017-09-01       Impact factor: 7.638

4.  BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsis.

Authors:  Byron Brook; Danny J Harbeson; Casey P Shannon; Bing Cai; Daniel He; Rym Ben-Othman; Freddy Francis; Joe Huang; Natallia Varankovich; Aaron Liu; Winnie Bao; Morten Bjerregaard-Andersen; Frederik Schaltz-Buchholzer; Lilica Sanca; Christian N Golding; Kristina Lindberg Larsen; Ofer Levy; Beate Kampmann; Rusung Tan; Adrian Charles; James L Wynn; Frank Shann; Peter Aaby; Christine S Benn; Scott J Tebbutt; Tobias R Kollmann; Nelly Amenyogbe
Journal:  Sci Transl Med       Date:  2020-05-06       Impact factor: 17.956

5.  NK Cell-Derived IL-10 Supports Host Survival during Sepsis.

Authors:  Isaac J Jensen; Patrick W McGonagill; Noah S Butler; John T Harty; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2021-01-29       Impact factor: 5.422

Review 6.  Mechanisms and modulation of sepsis-induced immune dysfunction in children.

Authors:  Leena B Mithal; Mehreen Arshad; Lindsey R Swigart; Aaruni Khanolkar; Aisha Ahmed; Bria M Coates
Journal:  Pediatr Res       Date:  2021-12-24       Impact factor: 3.756

7.  Antibiotics with Interleukin-15 Inhibition Reduce Joint Inflammation and Bone Erosions but Not Cartilage Destruction in Staphylococcus aureus-Induced Arthritis.

Authors:  Berglind Bergmann; Pernilla Jirholt; Petra Henning; Catharina Lindholm; Claes Ohlsson; Iain B McInnes; Ulf H Lerner; Inger Gjertsson
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

Review 8.  Targeting Immune Cell Checkpoints during Sepsis.

Authors:  Naeem K Patil; Yin Guo; Liming Luan; Edward R Sherwood
Journal:  Int J Mol Sci       Date:  2017-11-14       Impact factor: 5.923

9.  Treatment with Recombinant Interleukin-15 (IL-15) Increases the Number of T Cells and Natural Killer (NK) Cells and Levels of Interferon-γ (IFN-γ) in a Rat Model of Sepsis.

Authors:  Xianyuan Zhao; Hong Qi; Jiamin Zhou; Shuqi Xu; Yuan Gao
Journal:  Med Sci Monit       Date:  2019-06-15

10.  Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.

Authors:  Isaac J Jensen; Christina S Winborn; Micaela G Fosdick; Peng Shao; Mikaela M Tremblay; Qiang Shan; Sandeep Kumar Tripathy; Christopher M Snyder; Hai-Hui Xue; Thomas S Griffith; Jon C Houtman; Vladimir P Badovinac
Journal:  PLoS Pathog       Date:  2018-10-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.